Drug
Rapamycin
Rapamycin: highest development phase Phase 2, developed by Astellas. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Astellas
Trials
| Drug | Phase | Indication |
|---|---|---|
| Rapamycin NCT00533442 | Phase 2 | Type 1 Diabetes |
Latest
No recent events.
Follow Rapamycin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.